Gut Dysbiosis in Spinal Cord Injury Rehabilitation
SCIMBIONT
Spinal Cord Injury Rehabilitation: Gut Dysbiosis and Immune Biomarkers As Functional Prognosis Tools and New Therapeutic Targets - a Longitudinal Prospective Cohort Study
1 other identifier
observational
106
1 country
1
Brief Summary
The goal of this study is to investigate the role of gut microbiota, and related immune biomarkers and metabolites, in the functional recovery of spinal cord injury patients during the subacute phase. The main question it aims to answer is: How does gut microbiota dysbiosis impact functional recovery in subacute SCI patients, in a way that future targeted probiotic interventions may improve SCI outcomes?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2023
CompletedFirst Submitted
Initial submission to the registry
March 18, 2025
CompletedFirst Posted
Study publicly available on registry
March 24, 2025
CompletedMarch 24, 2025
March 1, 2025
2.5 years
March 18, 2025
March 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in intestinal microbiota
Microbiota relative abundance of different taxonomic levels to estimate change in alpha-diversity (diversity within different samples from the same individual) and in beta-diversity (diversity between groups) from hospital admission to 1-year post-injury
From hospital admission until to one-year post-injury
Change in functional independence from hospital admission to 1-year post-injury
Change in functional independence, as measured by the Spinal Cord Independence Measure, 4th version (SCIM IV) and by Functional Independence Measure (FIM), from hospital admission to 1-year post-injury.
From hospital admission until to one-year post-injury
Change in neuromotor impairment from hospital admission to 1-year post-injury
Change in the total ASIA Impairment Scale (AIS) motor score from hospital admission to 1-year post-injury.
From hospital admission until to one-year post-injury
Secondary Outcomes (3)
Change in bowel function from hospital admission to 1-year post-injury
From hospital admission until to one-year post-injury
Change in immunological and inflammation biomarkers
From hospital admission until to one-year post-injury
Change in gut microbiota-produced metabolites
From hospital admission until to one-year post-injury
Study Arms (3)
Spinal cord injury patients - A or B AIS classification
Spinal cord injury patients admitted for hospitalization at Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia / Espinho, E.P.E. with A (complete) or B (sensory incomplete) classification in The American Spinal Injury Association (ASIA) Impairment Scale (AIS)
Spinal cord injury patients - C or D AIS classification
Spinal cord injury patients admitted for hospitalization at Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia / Espinho, E.P.E. with C or D (motor incomplete) classification in The American Spinal Injury Association (ASIA) Impairment Scale (AIS)
Able-bodied controls
Age, gender and body mass index matched control group of participants recruited among able-bodied personnel from Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia / Espinho, E.P.E. or their relatives, without any known CNS disease
Eligibility Criteria
Patients admitted to Centro de Reabilitação do Norte (CRN) / Unidade Local de Saúde de Gaia e Espinho (ULSGE), between 1st of May 2021 and 16th of October 2023, following a traumatic spinal cord injury.
You may qualify if:
- Adults (≥18 years) with traumatic spinal cord injury.
- Injury occurred less than 6 months ago (subacute phase).
- Any neurological level of injury (AIS A-D).
You may not qualify if:
- Use of probiotics or immunomodulatory drugs in the last month.
- Major gastrointestinal surgery in the last 5 years.
- Active gastrointestinal diseases or other CNS diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centro Academico Clínico Egas Moniz Health Alliancelead
- Centro de Reabilitacao do Nortecollaborator
- Unidade Local de Saude de Gaia e Espinho EPEcollaborator
- Aveiro Institute of Biomedicine (iBiMED)collaborator
- Aveiro Universitycollaborator
Study Sites (1)
Centro de Reabilitação do Norte (CRN) / Unidade Local de Saúde Gaia e Espinho (ULSGE)
Vila Nova de Gaia, Porto District, 4405 - 565 Vila Nova de Gaia, Portugal
Biospecimen
Fecal and blood samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Ribeiro da Cunha, PhD
Centro de Reabilitação do Norte (CRN) / Unidade Local de Saúde Gaia e Espinho (ULSGE))
- STUDY DIRECTOR
Sandra Vieira
Institute of Biomedicine - Aveiro University (iBiMED-UA)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2025
First Posted
March 24, 2025
Study Start
May 1, 2021
Primary Completion
October 16, 2023
Study Completion
October 16, 2023
Last Updated
March 24, 2025
Record last verified: 2025-03